GLP-1s
US$ 21.25
glp-1 support platforms private companies Up GLP-1 Costs Explained: Managing Coverage
Description
The GRADE assessment rated 24 outcomes (20%) as High, 17 (14%) as Moderate, 25 (21%) as Low, and 52 (44%) as Very Low
Patients should be aware that access to retatrutide outside of clinical trials is not currently possible through NHS or private prescribing channels in the UK
Potential cardiovascular benefits
Just smart, science-backed care tailored to your life
Why it happens: Retatrutide includes glucagon receptor activation, which has metabolic effects including slight heart rate increase
GLP-1R agonist 13 GLP-1R agonist 13 (Compound 24) is a GLP-1 receptor agonist
